Sign in
4

Changes in Ownership

Serina Therapeutics, Inc. Filed Acc 0001301120-25-000005

Chief Scientific Officer sold 47,674 shares at an average $6.95 ($331,418)

  • Chief Scientific Officer acquired 47,674 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Moreadith Randall · Chief Scientific Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-25 Exercise or conversion : show line 1 in the form 10b5-1 +2,042 $0.06 $123 2,042 D
2025-08-26 Exercise or conversion : show line 2 in the form 10b5-1 +45,632 $0.06 $2,738 45,632 D
2025-08-25 Sale : show line 3 in the form 10b5-1 −2,042 $5.65 $11,537 0 D
2025-08-26 Sale : show line 4 in the form 10b5-1 −45,632 $7.01 $319,880 0 D
Open-market sales · 47,674 sh · avg $6.95 · $331,418

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-08-25 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −2,042 467,144 D
2025-08-26 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −45,632 421,512 D
Loading xslF345X05/wk-form4_1756329396.xml…